top of page

Myriad’s BRCA Gene Patent Wars Continue – A New Entrant Joins the Fray

  • Writer: Kirk Hartley
    Kirk Hartley
  • Oct 9, 2013
  • 1 min read

The Myriad BRCA gene patent wars are continuing, and a new entrant has started a new fray by suing Myriad in a declaratory judgment suit. The Genomics Law Report provides a cogent summary.

Recent Posts

See All

Comments


About Kirk

Since becoming a lawyer in 1983, Kirk’s 35+ years of practice have focused on advising a wide range of corporations, associations, and individuals (as both plaintiffs and defendants) on both tort and commercial law issues centered around “mass torts.”

Read More...

Copyright © 2020, GlobalTort All Rights Reserved.
bottom of page